Effects of Exercise on Lipoprotein Particles in Women with Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 28 of the 30 references it cites were found in a registry or an index.
Abstract
PURPOSE: Women with polycystic ovary syndrome (PCOS) commonly have insulin resistance. Insulin resistance is associated with marked abnormalities of lipoprotein size and subclass particle concentration. The purpose of this study was to examine the effects of a moderate-intensity exercise program without weight loss on lipoprotein profiles in women with PCOS. METHODS: Thirty-seven sedentary PCOS women were randomized to either an 8- to 12-wk ramp-up followed by a 12-wk moderate-intensity exercise program (16-24 wk total, approximately 228 min x wk at 40-60% peak V x O2, n = 21) or control (no change in lifestyle, n = 16). PCOS was defined as or=8). Fasting lipoprotein profiles were obtained before and after the intervention. Nuclear magnetic resonance spectroscopy was used to quantify the following: average particle size, total and subclass concentrations of HDL, LDL, and VLDL particles, and calculated HDL cholesterol, triglycerides, and VLDL triglycerides. Wilcoxon exact rank sums tests were used to compare changes in these parameters in the exercise group relative to controls. RESULTS: Twenty women (8 exercisers, 12 controls) completed the study. Comparing exercisers to controls, significant changes were seen in concentrations of the following lipoprotein parameters that are associated with decreased insulin resistance: decreased large VLDL (P = 0.007), calculated triglycerides (P = 0.003), VLDL triglycerides (P = 0.003), and medium/small HDL (P = 0.031) and increased large HDL (P = 0.002) and average HDL size (P = 0.001). CONCLUSIONS: In this trial, moderate-intensity exercise without significant weight loss improved several components of the lipoprotein profiles of women with PCOS. These findings support the beneficial role of moderate exercise in this high-risk population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One study was excluded from the meta-analysis [97] because data were reported as median and range values (attempts to contact the author were unsuccessful).”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [97]
Experimental — accuracy not yet measuredIn the citing paper
“Exercise was better than no exercise for triglycerides; 193”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“P olycystic ovary syndrome (PCOS) is associated with an increased risk of several metabolic complications including insulin resistance (6), type 2 diabetes (7,21), dyslipidemia (25–28), and possibly cardiovascular disease (3,27).”
BackgroundEffects of the amount and intensity of exercise on plasma lipoproteins
Kraus, W. E., Houmard, J. A., Duscha, B. D., Knetzger, K. J., Wharton, M. B., McCartney, J. S., Bales, C. W., Henes, S., Samsa, G. P., Otvos, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020194 · Cited by 1,554 · cited 2×
“Our exercise protocol was adapted from the STRRIDE study (18).”
BackgroundMethodSelf-citationPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 1×
“P olycystic ovary syndrome (PCOS) is associated with an increased risk of several metabolic complications including insulin resistance (6), type 2 diabetes (7,21), dyslipidemia (25–28), and possibly cardiovascular disease (3,27).”
BackgroundLamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Church, T. S., Earnest, C. P., Skinner, J. S., & Blair, S. N. (2007) · JAMA · doi:10.1001/jama.297.19.2081 · Cited by 756 · cited 1×
“In addition, this intensity with similar and lower volumes has been shown to improve cardiorespiratory fitness in other populations of women (4).”
BackgroundLipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy
Jeyarajah, E. J., Cromwell, W. C., & Otvos, J. D. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.006 · Cited by 732
Self-citationPrevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703
Cited by
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
“Even without weight loss, sedentary women with PCOS undergoing moderate-intensity exercise experience improved IR and dyslipidemia (106).”
BackgroundLifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K., Nestler, J. E., Sattar, N., & Lehnert, H. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1003 · Cited by 322
Lifestyle changes in women with polycystic ovary syndrome
Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub3 · Cited by 292
Exercise therapy in polycystic ovary syndrome: a systematic review
Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267
Farrell, K., & Antoni, M. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.081 · Cited by 209
“Surprisingly, in one of the studies, none of total or free testosterone or SHBG levels differed between the group of women whose ovulation resumed and those who remained anovulatory (99).”
BackgroundEnnour-Idrissi, K., Maunsell, E., & Diorio, C. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0647-3 · Cited by 193
Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Domecq, J. P., Prutsky, G., Mullan, R. J., Hazem, A., Sundaresh, V., Elamin, M. B., Phung, O. J., Wang, A., Hoeger, K., Pasquali, R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2385 · Cited by 184
“Groups BMI Subject Characteristics Funding Main Conclusions Brown et al, 2009 (32)a 18–50 6 11 LSM 38 Exercise: patients were assigned to a moderate to intensive exercise program for 5 6 mo; the load work per subject was 228 min/wk NFP Moderate-intensity exercise without significant weight loss improved several compon…”
MethodResultInfluentialExercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Patten, R. K., Boyle, R. A., Moholdt, T., Kiel, I., Hopkins, W. G., Harrison, C. L., & Stepto, N. K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00606 · Cited by 163
Almenning, I., Rieber-Mohn, A., Lundgren, K. M., Shetelig Løvvik, T., Garnæs, K. K., & Moholdt, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138793 · Cited by 155
“Previous randomized controlled trials on the isolated effect on IR after endurance training in women with PCOS have been using moderate intensity [26–28].”
MethodKite, C., Lahart, I. M., Afzal, I., Broom, D. R., Randeva, H., Kyrou, I., & Brown, J. E. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0962-3 · Cited by 155
Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
Setji, T. L., & Brown, A. J. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.04.017 · Cited by 145
Self-citationKazemi, M., McBreairty, L. E., Chizen, D. R., Pierson, R. A., Chilibeck, P. D., & Zello, G. A. (2018) · Nutrients · doi:10.3390/nu10101387 · Cited by 118
Varady, K. A., Bhutani, S., Klempel, M. C., & Kroeger, C. M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-119 · Cited by 116
“[15] demonstrated significant decreases in the proportion of small HDL particles after 12 weeks of endurance training in obese women with only 2% weight loss.”
BackgroundResultA Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
Shele, G., Genkil, J., & Speelman, D. (2020) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk5020035 · Cited by 115
Life Modifications and PCOS: Old Story But New Tales
Gu, Y., Zhou, G., Zhou, F., Wu, Q., Ma, C., Zhang, Y., Ding, J., & Hua, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.808898 · Cited by 103
Haqq, L., McFarlane, J., Dieberg, G., & Smart, N. (2014) · Endocrine Connections · doi:10.1530/ec-14-0010 · Cited by 101
The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions
Sarzynski, M. A., Burton, J., Rankinen, T., Blair, S. N., Church, T. S., Després, J.-P., Hagberg, J. M., Landers-Ramos, R., Leon, A. S., Mikus, C. R., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.018 · Cited by 98
Self-citationDiagnosis and Management of Polycystic Ovary Syndrome in Adolescents
Trent, M., & Gordon, C. M. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2056j · Cited by 84
Exercise and Polycystic Ovary Syndrome
Woodward, A., Klonizakis, M., & Broom, D. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_8 · Cited by 77
Vizza, L., Smith, C. A., Swaraj, S., Agho, K., & Cheema, B. S. (2016) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-016-0039-8 · Cited by 74
“Previous studies of exercise training in PCOS have reported participant attrition rates ranging from 25 % to 45 % [14, 45, 47–49, 51], while other studies have not provided these data [46, 48, 52].”
BackgroundMethodResultInfluentialThomson, R. L., Buckley, J. D., & Brinkworth, G. D. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00758.x · Cited by 70
“(70) showed in 20 sedentary women with PCOS that a 5-month supervised aerobic exercise programme (~228 min per week at 60% VO2max) had no effect on weight, waist circumference (WC) or fasting insulin; but a trend for improved area under the insulin curve (-26%).”
BackgroundPatten, R. K., Pascoe, M. C., Moreno‐Asso, A., Boyle, R. A., Stepto, N. K., & Parker, A. G. (2021) · BMC Public Health · doi:10.1186/s12889-021-12280-9 · Cited by 66
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010334.pub2 · Cited by 65
Greenwood, E. A., Noel, M., Kao, C., Shinkai, K., Pasch, L. A., Cedars, M. I., & Huddleston, H. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.10.020 · Cited by 65
Lie Fong, S., Douma, A., & Verhaeghe, J. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101894 · Cited by 64
Ribeiro, V. B., Kogure, G. S., Lopes, I. P., Silva, R. C., Pedroso, D. C. C., de Melo, A. S., de Souza, H. C. D., Ferriani, R. A., Furtado, C. L. M., & dos Reis, R. M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14194 · Cited by 64
Exercise Recommendations for Women with Polycystic Ovary Syndrome: Is the Evidence Enough?
Stepto, N. K., Patten, R. K., Tassone, E. C., Misso, M. L., Brennan, L., Boyle, J. A., Boyle, R. A., Harrison, C. L., Hirschberg, A. L., Marsh, K. A., et al. (2019) · Sports Medicine · doi:10.1007/s40279-019-01133-6 · Cited by 54
Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 53
Proteomic and metabolomic approaches to the study of polycystic ovary syndrome
Insenser, M. R., Montes‐Nieto, R., Murri, M., & Escobar-Morreale, H. F. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.009 · Cited by 52
Mohammadi, S., Monazzami, A., & alavimilani, S. (2023) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-023-00653-z · Cited by 51
Azevedo, J., & Mundstock, E. (2018) · Revista Brasileira de Ciências do Esporte · doi:10.1016/j.rbce.2018.03.017 · Cited by 46
Breyley-Smith, A., Mousa, A., Teede, H. J., Johnson, N. A., & Sabag, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031386 · Cited by 43
Selvaraj, V., Vanitha, J., Dhanaraj, F. M., Sekar, P., & Babu, A. R. (2020) · Health Science Reports · doi:10.1002/hsr2.212 · Cited by 39
Roessler, K. K., Birkebaek, C., Ravn, P., Andersen, M. S., & Glintborg, D. (2013) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12064 · Cited by 38
“Previous studies applied individual training programs (11,20,21) but training in groups may enhance the motivation to exercise and therefore increase weight loss and VO2max.”
Baskind, N. E., McRae, C., Sharma, V., & Fisher, J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq039 · Cited by 36
Gourgari, E., Lodish, M. B., Shamburek, R. D., Keil, M. F., WESLEY, R. A., Walter, M. F., Sampson, M. L., Bernstein, S. B., Khurana, D., Lyssikatos, C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2566 · Cited by 36
Zuuren, E. J., & Fedorowicz, Z. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14486 · Cited by 35
Abazar, E., Taghian, F., Mardanian, F., & Forozandeh, D. (2015) · Advanced Biomedical Research · doi:10.4103/2277-9175.153892 · Cited by 34
Roessler, K. K., Glintborg, D., Ravn, P., Birkebaek, C., & Andersen, M. (2013) · Communication & Medicine · doi:10.1558/cam.v9i2.125 · Cited by 34
Covington, J. D., Bajpeyi, S., Moro, C., Tchoukalova, Y. D., Ebenezer, P. J., Burk, D. H., Ravussin, É., & Redman, L. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0492 · Cited by 32
Nasiri, M., Monazzami, A., alavimilani, S., & Asemi, Z. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01793-0 · Cited by 29
Exercise in polycystic ovarian syndrome: An evidence-based review
Chandrasekaran, B., Shetty, D. R., Singh, A., & Oliverraj, J. (2017) · Saudi Journal of Sports Medicine · doi:10.4103/sjsm.sjsm_10_17 · Cited by 28
Cheema, B. S., Vizza, L., & Swaraj, S. (2014) · Sports Medicine · doi:10.1007/s40279-014-0206-6 · Cited by 27
Costa, E. C., de Sá, J. C. F., Costa, I. B. B., Meireles, R. D. S. R. V., Lemos, T. M. A. M., Elsangedy, H. M., Krinski, K., & Azevedo, G. D. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1092132 · Cited by 27
Acute changes in lipoprotein subclasses during exercise
Søndergaard, E., Poulsen, M. K., Jensen, M. D., & Nielsen, S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.011 · Cited by 25
Pharmacological and non-pharmacological strategies for obese women with subfertility
Taghavi, S. A., van Wely, M., Jahanfar, S., & Bazarganipour, F. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012650.pub2 · Cited by 23
Lee, H., & Lee, S.-H. (2023) · Life · doi:10.3390/life13071533 · Cited by 22
“While traditional lifestyle modifications have been effective [16], face-to-face intervention programs have encountered a dropout rate as high as 62%, often because of time constraints [17,18].”
BackgroundMotaharinezhad, F., Emadi, A., Hosnian, M., Kheirkhahan, A., Jayedi, A., & Ehsani, F. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03297-4 · Cited by 22
Alkoudsi, K. T., & Basheti, I. A. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.08.027 · Cited by 22
Is cardiorespiratory fitness impaired in PCOS women? A review of the literature
Donà, S., Bacchi, E., & Moghetti, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0599-1 · Cited by 20
Khatlani, K., Njike, V., & Costales, V. C. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0049 · Cited by 20
Polycystic Ovary Syndrome: An Overview
Whitaker, K. N. (2010) · Journal of Pharmacy Practice · doi:10.1177/0897190010384632 · Cited by 20
Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review
Anwar, S., & Shikalgar, N. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.07.015 · Cited by 20
Baldani, D. P., Skrgatic, L., Ougouag, R., & Kasum, M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1381681 · Cited by 17
Role of Lifestyle and Diet in the Management of Polycystic Ovarian Syndrome
Krystock, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_9 · Cited by 13
Alkoudsi, K. T., Alqudah, R., & Basheti, I. A. (2019) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13310 · Cited by 13
Wattar, B. H. A., Hussain, N., & Khan, K. S. (2022) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2021.10.010 · Cited by 13
Khalafi, M., Symonds, M. E., Ghasemi, F., Rosenkranz, S. K., Rohani, H., & Sakhaei, M. H. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110741 · Cited by 10
Koçak, S., Çalışkan, H., Ömercioğlu, G., Akat, F., Billur, D., İnanç, İ., Fıçıcılar, H., & Baştuğ, M. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114794 · Cited by 8
Cavalcante, D. C. B., Scandolara, T. B., Kogure, G. S., Rodrigues, C. G., Verruma, C. G., de Moraes, M. O., dos Reis, R. M., Cavalcante, M. B., & Furtado, C. L. M. (2025) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2025rbgo56 · Cited by 7
Porter, R. R., Sparks, J. R., Durstine, J. L., Custer, S., Thompson, R. W., & Wang, X. (2023) · Geriatrics · doi:10.3390/geriatrics8060116 · Cited by 7
Herzig, K., Leppäluoto, J., Jokelainen, J. J., Meugnier, E., Pesenti, S., Selänne, H., Mäkelä, K. A., Ahola, R., Jämsä, T. J., Vidal, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09753-6 · Cited by 7
Bezerra, A. I. L., Kanegusuku, H., do Prado, W. L., Ritti‐Dias, R. M., & Júnior, C. C. (2013) · Revista Brasileira de Atividade Física & Saúde · doi:10.12820/rbafs.v.18n4p399 · Cited by 7
Li, L., Ma, J., Sun, N., Hu, P., Lin, Y., & Zhang, Q. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00955-8 · Cited by 6
Sánchez, M., Rietmann, L. M. F., Bajana, A. M., Rodriguez, C. F. C., Díaz, T. A. M., Sultana, S., Vera, D. C., Cogollos, C. S., Franco, M. D. L. L., Gonzalez, M., et al. (2026) · BMC Women s Health · doi:10.1186/s12905-025-04201-4 · Cited by 6
Physical Activity, Exercise, and Lipids and Lipoproteins
Durstine, J. L., Anderson, E., Porter, R. R., & Wang, X. (2019) · Springer eBooks · doi:10.1007/978-3-030-04816-7_16 · Cited by 7
Roessler, K. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803634-1.00021-2 · Cited by 5
Patten, R. K. (2021) · Victoria University Research Repository (Victoria University) · Cited by 5
Koduri, P., Chinta, P., Kunjummen, A. T., Yadav, B., Kapoor, N., Paravathareddy, S., Vimala, & Kamath, M. S. (2024) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_111_24 · Cited by 4
Vasheghani-Farahani, F., Khosravi, S., Yekta, A. H. A., Rostami, M., & Mansournia, M. A. (2017) · Novelty in biomedicine · doi:10.22037/nbm.v5i1.15845 · Cited by 4
Effects of Exercise Intervention on the Improvement of Polycystic Ovary Syndrome
Wang, S., Zhang, Z., & Liu, Y. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88896 · Cited by 4
Pharmacological and non-pharmacological strategies for obese women with subfertility
Taghavi, S. A., van Wely, M., Jahanfar, S., & Bazarganipour, F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012650 · Cited by 4
The effectiveness of exercise in the treatment of polycystic ovary syndrome
Kite, C. (2020) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00042574 · Cited by 4
The Role of Diet and Lifestyle Modification in the Treatment of Polycystic Ovary Syndrome
Thomson, R. L., Teede, H. J., Stepto, N. K., Banting, L., & Moran, L. (2015) · CRC Press eBooks · doi:10.1201/b18190-3 · Cited by 3
Novel concepts in lipoprotein particle metabolism and regulation
Aronis, K. N., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.002 · Cited by 3
Small dense low-density lipoprotein particles: priority as a treatment target in Type 2 diabetes?
Gerber, P. A., Spinas, G. A., & Berneis, K. K. (2011) · Diabetes Management · doi:10.2217/dmt.11.73 · Cited by 3
Fathei, M., & Nastaran, M. (2014) · International journal of sport studies · Cited by 3
Polycystic Ovary Syndrome: Update on Treatment Options and Treatment Considerations for the Future
Farrell-Turner, K. A. (2011) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s6715 · Cited by 3
Khalafi, M., Fatolahi, S., Rahmatpanah, G., Symonds, M. E., Rosenkranz, S. K., Dinizadeh, F., & Batrakoulis, A. (2026) · BMC Women s Health · doi:10.1186/s12905-025-04240-x · Cited by 2
Wan, K., Dai, Z.-H., Lei, E., Wong, P.-S., Wang, Y.-Y., Yu, A. P., Lin, F., Huang, Y., Duncan, W. C., Chan, K. Y., et al. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(25)00219-5 · Cited by 2
Vizza, L. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.113149 · Cited by 2
Role of structured exercise programs in polycystic ovary syndrome: a systematic review
Bansal, A., Sethi, J., & Parasher, R. K. (2023) · Physical Therapy Reviews · doi:10.1080/10833196.2022.2163076 · Cited by 2
Ann, M., Chinta, P., Koduri, P., Kunjummen, A. T., & Kamath, M. S. (2025) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_173_24 · Cited by 2
Treatments for Improving Psychological Health in PCOS
Barry, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30290-0_8 · Cited by 2
da Silva, J. L. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-23112011-185508 · Cited by 2
Woodward, A. (2016) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Physical activity and cardiovascular disease risk in women with polycystic ovary syndrome
Woodward, A. (2021) · Sheffield Hallam University · doi:10.7190/shu-thesis-00398 · Cited by 2
Mani, H. (2014) · Figshare · Cited by 2
Effect of Wolly Workout in PCOS and PCOD Patients as Part of Management
Tripathi, P. P. (2023) · SSR Institute of International Journal of Life Sciences · doi:10.21276/ssr-iijls.2023.9.4.7 · Cited by 1
Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
Gaisamudre, K. N., Sarwade, S. P., Sarwade, P. P., Singh, D., Srinandhinidevi, K. M., Rani, M. J., Kavita, J., & Chirmade, D. H. (2024) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.3.5.4 · Cited by 1
Polycystic Ovary Syndrome: Dietary Approaches to Counteract Insulin Resistance
Das, I. (2020) · Journal of Undergraduate Life Sciences · doi:10.33137/juls.v14i1.35925 · Cited by 1
Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch14 · Cited by 1
Exercise interventions in women with Polycystic Ovary Syndrome
Moreno‐Asso, A., Patten, R. K., & McIlvenna, L. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89843-0.00020-9 · Cited by 1
Importance of lifestyle modifications
Das, B., & Fatima, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00030-x · Cited by 1
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Gonçalves, T. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-21022018-104859
Metadata
- Authors
- BROWN, A. J., SETJI, T. L., SANDERS, L. L., LOWRY, K. P., OTVOS, J. D., KRAUS, W. E., & SVETKEY, P. L.
- Affiliations
- Duke Medical Center (US)
- Venue
- Medicine & Science in Sports & Exercise
- Published
- 2009-03
- Volume
- 41
- Issue
- 3
- Pages
- 497-504
- ISSN
- 0195-9131 (ISSN-L)
- PMC
- PMC2727938
- OpenAlex
- W2087545850
- Cited by
- 101
- References
- 30
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 4 · 2021: 4 · 2020: 8 · 2019: 9 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 9 · 2014: 6 · 2013: 8 · 2012: 2
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Medicine & Science in Sports & Exercise (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL04390-01, K23HL004390)
- National Center for Research Resources (MO 1 RR-30)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- polycystic ovary syndrome, moderate-intensity exercise, lipoprotein particles, insulin resistance, HDL cholesterol, VLDL triglycerides, triglycerides, lipoprotein particle size, women
- MeSH terms
- Adult, Female, Humans, Lipoproteins, HDL, Lipoproteins, VLDL, Magnetic Resonance Spectroscopy, Oxygen Consumption, Particle Size, Polycystic Ovary Syndrome, Triglycerides, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.